{"transactions":[{"id":848876,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-03-11T20:01:30.000Z","date":"2026-03-09","kind":"tax_withholding","planned":false,"acquired":false,"shares":80666,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."}],"balance_after":639583,"source":{"system":"sec-edgar","filing":"0001628280-26-016794","document":"wk-form4_1773259287.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026016794/wk-form4_1773259287.xml","form_type":"4"}},{"id":922116,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2026-02-03T21:16:46.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":4191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the number of shares of common stock that have been withheld by the Issuer to satisfy its income tax withholding and remittance obligations in connection with the net settlement of certain time-based restricted stock unit awards and does not represent an open market sale."}],"balance_after":720249,"source":{"system":"sec-edgar","filing":"0001628280-26-005014","document":"wk-form4_1770153401.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000162828026005014/wk-form4_1770153401.xml","form_type":"4"}},{"id":1215216,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim  PFO and PAO"}}],"security":"Stock Option (Right to Buy)","published_at":"2025-03-10T23:01:31.000Z","date":"2025-03-06","kind":"grant","planned":false,"acquired":true,"shares":1927073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"date","element":"transactionDate","label":"F3","text":"The option grant was approved by the Issuer's board of directors on December 20, 2024, subject to shareholder approval of the Amended and Restated Plan, under which the option was granted. The Issuer's shareholders approved the Amended and Restated Plan on March 6, 2025."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"Three-forty-eighth of the shares underlying this option vest on March 31, 2025 (\"Vesting Commencement Date\") and thereafter one-forty-eighth of the shares underlying this option vest in equal monthly installments from the Vesting Commencement Date, such that the option will be fully vested on the date forty-five months after the Vesting Commencement Date, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":1927073,"derivative":{"exercise_price":3.97,"expiration_date":"2034-12-19","underlying":"Common Stock","underlying_shares":1927073},"source":{"system":"sec-edgar","filing":"0001854270-25-000013","document":"wk-form4_1741647685.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000013/wk-form4_1741647685.xml","form_type":"4"}},{"id":1215215,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and Interim  PFO and PAO"}}],"security":"Common Stock","published_at":"2025-03-10T23:01:31.000Z","date":"2025-03-07","kind":"grant","planned":false,"acquired":true,"shares":642358,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan, as amended and restated (the \"Amended and Restated Plan\"). Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from March 7, 2025, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":724440,"source":{"system":"sec-edgar","filing":"0001854270-25-000013","document":"wk-form4_1741647685.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000013/wk-form4_1741647685.xml","form_type":"4"}},{"id":1280403,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-07T01:23:37.000Z","date":"2025-02-06","kind":"sale","planned":false,"acquired":false,"shares":545,"price":4.36,"value":2376.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":82082,"source":{"system":"sec-edgar","filing":"0001854270-25-000004","document":"wk-form4_1738891411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000004/wk-form4_1738891411.xml","form_type":"4"}},{"id":1280402,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO"}}],"security":"Common Stock","published_at":"2025-02-07T01:23:37.000Z","date":"2025-02-04","kind":"sale","planned":false,"acquired":false,"shares":3922,"price":4.07,"value":15962.54,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The Issuer has adopted a \"sell-to-cover\" policy to satisfy the tax withholding obligations of the Reporting Person. The sales reported on this Form 4 represent the number of shares required to be sold by the Reporting Person to cover tax withholding obligations in connection with the vesting of restricted stock units. Such sales were automatic and not at the discretion of the Reporting Person."}],"balance_after":82627,"source":{"system":"sec-edgar","filing":"0001854270-25-000004","document":"wk-form4_1738891411.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427025000004/wk-form4_1738891411.xml","form_type":"4"}},{"id":1662068,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2024-02-02T22:27:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":459000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":459000,"derivative":{"exercise_price":0.46,"expiration_date":"2034-01-31","underlying":"Common Stock","underlying_shares":459000},"source":{"system":"sec-edgar","filing":"0001854270-24-000015","document":"wk-form4_1706912814.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000015/wk-form4_1706912814.xml","form_type":"4"}},{"id":1662067,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Common Stock","published_at":"2024-02-02T22:27:09.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":306000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The shares reported in this transaction represent restricted stock units (\"RSUs\") issued under the Senti Biosciences, Inc. 2022 Equity Incentive Plan. Each RSU represents the contingent right to receive one share of the Issuer's Common Stock. All of the shares underlying the award vest in three substantially equal annual installments over three years from February 1, 2024, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":865496,"source":{"system":"sec-edgar","filing":"0001854270-24-000015","document":"wk-form4_1706912814.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427024000015/wk-form4_1706912814.xml","form_type":"4"}},{"id":2036478,"issuer":{"id":7935,"kind":"organization","name":"Senti Biosciences Holdings, Inc."},"owners":[{"id":61523,"kind":"person","name":"Lu Timothy K","position":1,"cik":"0001852301","reported_name":"Lu Timothy K","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CEO and President"}}],"security":"Stock Option (Right to Buy)","published_at":"2023-02-02T22:20:19.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":630000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option vest in 48 substantially equal monthly installments over four years from February 1, 2023, subject to the reporting person's continued service through the applicable vesting date."}],"balance_after":630000,"derivative":{"exercise_price":1.81,"expiration_date":"2033-01-31","underlying":"Common Stock","underlying_shares":630000},"source":{"system":"sec-edgar","filing":"0001854270-23-000017","document":"wf-form4_167537640361956.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1854270/000185427023000017/wf-form4_167537640361956.xml","form_type":"4"}}]}